Package | hl7.fhir.uv.cpg |
Resource Type | PlanDefinition |
Id | cc-cpg-plan-ckd |
FHIR Version | R4 |
Source | http://hl7.org/fhir/uv/cpg/https://build.fhir.org/ig/HL7/cqf-recommendations/PlanDefinition-cc-cpg-plan-ckd.html |
URL | http://hl7.org/fhir/uv/cpg/PlanDefinition/cc-cpg-plan-ckd |
Version | 2.0.0 |
Status | active |
Date | 2024-11-26T06:42:34+00:00 |
Name | ChronicKidneyDiseaseAmbulatory |
Realm | uv |
Authority | hl7 |
Description | Chronic Kidney Disease - Ambulatory |
Copyright | Copyright © Elsevier, and others. |
No resources found
No resources found
Note: links and images are rebased to the (stated) source
Generated Narrative: PlanDefinition cc-cpg-plan-ckd
CQF Knowledge capability: shareable
CQF Knowledge capability: computable
CQF Knowledge capability: publishable
url: PlanDefinition ChronicKidneyDiseaseAmbulatory
identifier: Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.48.34.21
version: 2.0.0
name: ChronicKidneyDiseaseAmbulatory
type: Order Set
status: Active
experimental: true
date: 2024-11-26 06:42:34+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description:
Chronic Kidney Disease - Ambulatory
Code | Value[x] |
UsageContextType focus: Clinical Focus | Chronic kidney disease (disorder) |
jurisdiction: World
copyright:
Copyright © Elsevier, and others.
topic: Treatment
relatedArtifact
type: Justification
display: SYNOPSIS - Chronic Kidney Disease KEY POINTS Decline in function of the kidney characterized by at least 3 months of reduced GFR (less than 60 mL/minute/ 1.73 m²) or at least 3 months of structural or functional kidney damage Assessment of both GFR and albuminuria is necessary to diagnose chronic kidney disease and monitor disease progression GFR is most commonly estimated through measuring serum creatinine and the use of GFR estimating equations, either the Modification of Diet in Renal Disease Study equation or the Chronic Kidney Disease Epidemiology Collaboration equation Albuminuria is measured by urine albumin/creatinine ratio; greater than 30 mg/g indicates albuminuria Chronic kidney disease is commonly associated with hypertension, diabetes, and cardiovascular disease First line therapy includes ACE inhibitors and/or angiotensin II receptor blockers to reduce albuminuria and hypertension If left untreated, chronic kidney disease can progress to end-stage renal disease requiring dialysis or renal transplant Symptoms of end-stage renal disease (eg, pruritus, refractory electrolyte imbalances, metabolic acidosis, severe nausea, neurologic impairments) typically occur when GFR is 5 to 10 mL/minute/1.73 m² Carefully monitor electrolyte levels, hemoglobin, parathyroid hormone levels, and sodium bicarbonate levels to detect complications of chronic kidney disease, including cardiovascular disease, anemia, bone mineral disease, and metabolic acidosis URGENT ACTION Hyperkalemia may require urgent treatment in patients being treated for chronic kidney disease Urgent treatment consists of calcium chloride or calcium gluconate and regimens of sodium bicarbonate, glucose and insulin, or nebulized albuterol PITFALLS Early stages are often asymptomatic, causing chronic kidney disease to be untreated, leading to further progression of kidney damage and worse prognosis
citation:
Chronic Kidney Disease Clinical Overview. ClinicalKey. Source
Documents
Url http://himss19.ordersetsmanager.com/evidenceviewer/#/7CBBBE9B75E10232E05352E3610A5325/7CBBBE9B75E10232E05352E3610A5325
action
id
cc-cpg-activity-referral-nephrologytitle: Referrals
groupingBehavior: Visual Group
action
id
34387224title: Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]
description: Referrals
requiredBehavior: Could
precheckBehavior: No
definition: ReferralNephrology
action
id
cc-cpg-activity-referral-dietitiontitle: Referral: Dietitian; History: chronic kidney disease; Question: [add reason for referral]
description: Referrals
requiredBehavior: Could
precheckBehavior: No
definition: ReferralDietitian
{ "resourceType": "PlanDefinition", "id": "cc-cpg-plan-ckd", "meta": { "profile": [ "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-ordersetdefinition", "http://hl7.org/fhir/uv/cpg/StructureDefinition/cpg-computableplandefinition" ] }, "text": { "status": "extensions", "div": "<!-- snip (see above) -->" }, "extension": [ { "url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability", "valueCode": "shareable" }, { "url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability", "valueCode": "computable" }, { "url": "http://hl7.org/fhir/StructureDefinition/cqf-knowledgeCapability", "valueCode": "publishable" } ], "url": "http://hl7.org/fhir/uv/cpg/PlanDefinition/cc-cpg-plan-ckd", "identifier": [ { "system": "urn:ietf:rfc:3986", "value": "urn:oid:2.16.840.1.113883.4.642.40.48.34.21" } ], "version": "2.0.0", "name": "ChronicKidneyDiseaseAmbulatory", "type": { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/plan-definition-type", "code": "order-set", "display": "Order Set" } ] }, "status": "active", "experimental": true, "date": "2024-11-26T06:42:34+00:00", "publisher": "HL7 International / Clinical Decision Support", "contact": [ { "name": "HL7 International / Clinical Decision Support", "telecom": [ { "system": "url", "value": "http://www.hl7.org/Special/committees/dss" } ] } ], "description": "Chronic Kidney Disease - Ambulatory", "useContext": [ { "code": { "system": "http://terminology.hl7.org/CodeSystem/usage-context-type", "code": "focus", "display": "Clinical Focus" }, "valueCodeableConcept": { "coding": [ { "system": "http://snomed.info/sct", "code": "709044004", "display": "Chronic kidney disease (disorder)" } ] } } ], "jurisdiction": [ { "coding": [ { "system": "http://unstats.un.org/unsd/methods/m49/m49.htm", "code": "001", "display": "World" } ] } ], "copyright": "Copyright © Elsevier, and others.", "topic": [ { "coding": [ { "system": "http://terminology.hl7.org/CodeSystem/definition-topic", "code": "treatment", "display": "Treatment" } ], "text": "Treatment" } ], "relatedArtifact": [ { "type": "justification", "display": "SYNOPSIS - Chronic Kidney Disease\n\n\n\t\n\tKEY POINTS\n\n\t\n\t\tDecline in function of the kidney characterized by at least 3 months of reduced GFR (less than 60 mL/minute/ 1.73 m²) or at least 3 months of structural or functional kidney damage\n\t\tAssessment of both GFR and albuminuria is necessary to diagnose chronic kidney disease and monitor disease progression\n\t\tGFR is most commonly estimated through measuring serum creatinine and the use of GFR estimating equations, either the Modification of Diet in Renal Disease Study equation or the Chronic Kidney Disease Epidemiology Collaboration equation\n\t\tAlbuminuria is measured by urine albumin/creatinine ratio; greater than 30 mg/g indicates albuminuria\n\t\tChronic kidney disease is commonly associated with hypertension, diabetes, and cardiovascular disease\n\t\tFirst line therapy includes ACE inhibitors and/or angiotensin II receptor blockers to reduce albuminuria and hypertension\n\t\tIf left untreated, chronic kidney disease can progress to end-stage renal disease requiring dialysis or renal transplant\n\t\t\n\t\t\tSymptoms of end-stage renal disease (eg, pruritus, refractory electrolyte imbalances, metabolic acidosis, severe nausea, neurologic impairments) typically occur when GFR is 5 to 10 mL/minute/1.73 m²\n\t\t\n\t\t\n\t\tCarefully monitor electrolyte levels, hemoglobin, parathyroid hormone levels, and sodium bicarbonate levels to detect complications of chronic kidney disease, including cardiovascular disease, anemia, bone mineral disease, and metabolic acidosis\n\t\n\t\n\n\n\n\t\n\tURGENT ACTION\n\n\t\n\t\tHyperkalemia may require urgent treatment in patients being treated for chronic kidney disease\n\t\t\n\t\t\tUrgent treatment consists of calcium chloride or calcium gluconate and regimens of sodium bicarbonate, glucose and insulin, or nebulized albuterol\n\t\t\n\t\t\n\t\n\t\n\n\n\n\t\n\tPITFALLS\n\n\t\n\t\tEarly stages are often asymptomatic, causing chronic kidney disease to be untreated, leading to further progression of kidney damage and worse prognosis", "citation": "Chronic Kidney Disease Clinical Overview. ClinicalKey. Source", "url": "http://himss19.ordersetsmanager.com/evidenceviewer/#/7CBBBE9B75E10232E05352E3610A5325/7CBBBE9B75E10232E05352E3610A5325", "document": { "url": "http://himss19.ordersetsmanager.com/evidenceviewer/#/7CBBBE9B75E10232E05352E3610A5325/7CBBBE9B75E10232E05352E3610A5325" } } ], "action": [ { "id": "cc-cpg-activity-referral-nephrology", "title": "Referrals", "groupingBehavior": "visual-group", "action": [ { "id": "34387224", "title": "Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]", "description": "Referrals", "requiredBehavior": "could", "precheckBehavior": "no", "definitionCanonical": "http://hl7.org/fhir/uv/cpg/ActivityDefinition/cc-cpg-activity-referral-nephrology" }, { "id": "cc-cpg-activity-referral-dietition", "title": "Referral: Dietitian; History: chronic kidney disease; Question: [add reason for referral]", "description": "Referrals", "requiredBehavior": "could", "precheckBehavior": "no", "definitionCanonical": "http://hl7.org/fhir/uv/cpg/ActivityDefinition/cc-cpg-activity-referral-dietitian" } ] } ] }